Skip to content
healthcare.dev

Rezvoglar KwikPen

NDC 0002-8980, Insulin glargine-aglr, injection, solution, from Eli Lilly and Company.

Product NDC
0002-8980
Status
Listed
Labeler
Eli Lilly and Company
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761215
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0002-8980 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • INSULIN GLARGINE100 [iU]/mL

Pharmacologic classes

Insulin Analog [EPC]; Insulin [CS]

Package NDCNDC-11Package
0002-8980-05000028980055 SYRINGE in 1 CARTON (0002-8980-05) / 3 mL in 1 SYRINGE (0002-8980-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f6af8706-2058-4fe1-99c8-43684c20bfa2
  • NADAC price for package 00002898005

    GET /v1/drugs/nadac/00002898005

Use it

Look up 0002-8980 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0002-8980 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0002-8980. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.